Distinct roles for IP-10/C XC L10 in three animal models,Theiler’s virus infection,EA E,and MHV infection,for multiple sclerosis: implication of differing roles for IP-10
Restricted accessResearch articleFirst published online February, 2004
Distinct roles for IP-10/C XC L10 in three animal models,Theiler’s virus infection,EA E,and MHV infection,for multiple sclerosis: implication of differing roles for IP-10
Theiler’s murine encephalomyelitis virus (TMEV) causes demyelination with inflammation of the central nervous system (C NS) in mice and is used as an animal model for multiple sclerosis (MS). Interferon-g inducible protein-10 kDa (IP-10) is a C XC chemokine and a chemoattractant for C XC R3+ T cells. IP-10 mRNA is expressed in the C NS during TMEV infection. However, administration of anti-IP- 10 serum caused no difference in clinical signs, inflammation, demyelination, virus persistence or anti-virus antibody response in TMEV infection, while levels of virus specific and autoreactive lymphoproliferation increased. This likely reflects a difference in the pathogenesis of TMEV infection from that of two other animal models for MS, mouse hepatitis virus infection and experimental allergic encephalomyelitis (EAE), where blocking of IP-10 resulted in clinical and histological improvement with suppression of antigen specific lymphoproliferation. In this review, we compare and contrast the roles of IP-10 between the three animal models for MS, and discuss the relevance to MS patients with different clinical courses.
Zlotnik A , Yoshie O.Chemokines: a new classification system and their role in immunity . Immunity2000; 12: 121-127 .
2.
Sallusto F , Lanzavecchia A , Mackay CR.Chemokines and chemokine receptors in T-cell priming and Th1/Th2-mediated responses . Immunol Today1998; 19: 568-574 .
3.
Tanaka Y , Adams DH , Shaw S.Proteoglycans on endothelial cells present adhesion-inducing cytokines to leukocytes . Immunol Today1993; 14: 111-115 .
4.
Tanaka Y , Adams DH , Hubscher S , Hirano H , Siebenlist U , Shaw S.T-cell adhesion induced by proteoglycan-immobilized cytokine MIP-1b . Nature1993; 361: 79-82 .
5.
Soto H , Wang W , Strieter RM , Copeland NG , Gilbert DJ , Jenkins NA , Hedrick J , Zlotnik A.The CC chemokine 6Ckine binds the CXC chemokine receptor CXCR3 . Proc Natl Acad Sci USA1998; 95: 8205-8210 .
6.
Fischer FR , Santambrogio L , Luo Y , Berman MA , Hancock WW , Dorf ME.Modulation of experimental autoimmune encephalomyelitis: effect of altered peptide ligand on chemokine and chemokine receptor expression . J Neuroimmunol2000; 110: 195-208 .
7.
Xie JH , Nomura N , Lu M , Chen S-L , Koch GE , Weng Y , Rosa R , Di Salvo J , Mudgett J , Peterson LB , Wicker LS , DeMartino JA.Antibody-mediated blockade of the CXCR3 chemokine receptor results in diminished recruitment of T helper 1 cells into sites of inflammation . J Leukoc Biol2003; 73: 771-780 .
8.
Tsunoda I , Fujinami RS.Two models for multiple sclerosis: experimental allergic encephalomyelitis and Theiler’s murine encephalomyelitis virus . J Neuropathol Exp Neurol1996; 55: 673-686 .
9.
Tsunoda I , Fujinami RS.Theiler’s murine encephalomyelitis virus. In Ahmed R , Chen I eds. Persistent viral infections. Chichester:Wiley , 1999: 517-536.
10.
Lipton HL.Theiler’s virus infection in mice: an unusual biphasic disease process leading to demyelination . Infect Immunol1975; 11: 1147-1155 .
11.
Tsunoda I , Iwasaki Y , Terunuma H , Sako K , Ohara Y.A comparative study of acute and chronic diseases induced by two subgroups of Theiler’s murine encephalomyelitis virus . Acta Neuropathol (Berl)1996; 91: 595-602 .
12.
Tsunoda I , Kurtz CIB , Fujinami RS.Apoptosis in acute and chronic central nervous system disease induced by Theiler’s murine encephalomyelitis virus . Virology1997; 228: 388-393 .
13.
Tsunoda I , McCright IJ , Kuang L-Q , Zurbriggen A , Fujinami RS.Hydrocephalus in mice infected with a Theiler’s murine encephalomyelitis virus variant . J Neuropathol Exp Neurol1997; 56: 1302-1313 .
14.
Hoffman LM , Fife BT , Begolka WS , Miller SD , Karpus WJ.Central nervous system chemokine expression during Theiler’s virus-induced demyelinating disease . J NeuroVirol1999; 5: 635-642 .
15.
Murray PD , Krivacic K , Chernosky A , Wei T , Ransohoff RM , Rodriguez M.Biphasic and regionally-restricted chemokine expression in the central nervous system in the Theiler’s virus model of multiple sclerosis . J NeuroVirol2000; 6(Suppl 1): S44-S52 .
16.
Ransohoff RM , Wei T , Pavelko KD , Lee J-C , Murray PD , Rodriguez M.Chemokine expression in the central nervous system of mice with a viral disease resembling multiple sclerosis: roles of CD4+ and CD8+ T cells and viral persistence . J Virol2002; 76: 2217-2224 .
17.
Palma JP , Kim BS.Induction of selected chemokines in glial cells infected with Theiler’s virus . J Neuroimmunol2001; 117: 166-170 .
18.
Theil DJ , Tsunoda I , Libbey JE , Derfuss TJ , Fujinami RS.Alterations in cytokine but not chemokine mRNA expression during three distinct Theiler’s virus infections . J Neuroimmunol2000; 104: 22-30 .
19.
O’Garra A , McEvoy LM , Zlotnik A.T-cell subsets: chemokine receptors guide the way . Curr Biol1998; 8: R646-R649 .
20.
Sørensen TL , Tani M , Jensen J , Pierce V , Lucchinetti C , Folcik VA , Qin S , Rottman J , Sellebjerg F , Strieter RM , Frederiksen JL , Ransohoff RM.Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients . J Clin Invest1999; 103: 807-815 .
21.
Simpson JE , Newcombe J , Cuzner ML , Woodroofe MN.Expression of the interferon-g-inducible chemokines IP-10 and Mig and their receptor, CXCR3, in multiple sclerosis lesions . Neuropathol Appl Neurobiol2000; 26: 133-142 .
22.
Sørensen TL , Trebst C , Kivisäkk P , Klaege KL , Majmudar A , Ravid R , Lassmann H , Olsen DB , Strieter RM , Ransohoff RM , Sellebjerg F.Multiple sclerosis: a study of CXCL10 and CXCR3 co-localization in the inflamed central nervous system . J Neuroimmunol2002; 127: 59-68 .
23.
Balashov KE , Rottman JB , Weiner HL , Hancock WW.CCR5+ and CXCR3+ T cells are increased in multiple sclerosis and their ligands MIP-1a and IP10 are expressed in demyelinating brain lesions . Proc Natl Acad Sci USA1999; 96: 6873-6878 .
24.
Comabella M , Imitola J , Weiner HL , Khoury SJ.Interferon-b treatment alters peripheral blood monocytes chemokine production in MS patients . J Neuroimmunol2002; 126: 205-212 .
25.
Biddison WE , Cruikshank WW , Center DM , Pelfrey CM , Taub DD , Turner RV.CD8+ myelin peptide-specific T cells can chemoattract CD4+ myelin peptide-specific T cells: importance of IFN-inducible protein 10 . J Immunol1998; 160: 444-448 .
26.
Sørensen TL , Sellebjerg F , Jensen CV , Strieter RM , Ransohoff RM.Chemokines CXCL10 and CCL2: differential involvement in intrathecal inflammation in multiple sclerosis . Eur J Neurol2001; 8: 665-672 .
27.
Mahad DJ , Howell SJL , Woodroofe MN.Expression of chemokines in the CSF and correlation with clinical disease activity in patients with multiple sclerosis . J Neurol Neurosurg Psychiatry2002; 72: 498-502 .
28.
Franciotta D , Martino G , Zardini E , Furlan R , Bergamaschi R , Andreoni L , Cosi V.Serum and CSF levels of MCP-1 and IP-10 in multiple sclerosis patients with acute and stable disease and undergoing immunomodulatory therapies . J Neuroimmunol2001; 115: 192-198 .
29.
Teleshova N , Pashenkov M , Huang Y-M , Söderström M , Kivisäkk P , Kostulas V , Haglund M , Link H.Multiple sclerosis and optic neuritis: CCR5 and CXCR3 expressing T cells are augmented in blood and cerebrospinal fluid . J Neurol2002; 249: 723-729 .
30.
Kivisäkk P , Trebst C , Liu Z , Tucky BH , Sørensen TL , Rudick RA , Mack M , Ransohoff RM.T-cells in the cerebrospinal fluid express a similar repertoire of inflammatory chemokine receptors in the absence or presence of CNS inflammation: implications for CNS trafficking . Clin Exp Immunol2002; 129: 510-518 .
31.
Misu T , Onodera H , Fujihara K , Matsushima K , Yoshie O , Okita N , Takase S , Itoyama Y.Chemokine receptor expression on T cells in blood and cerebrospinal fluid at relapse and remission of multiple sclerosis: imbalance of Th1/Th2-associated chemokine signaling . J Neuroimmunol2001; 114: 207-212 .
32.
Liu MT , Chen BP , Oertel P , Buchmeier MJ , Armstrong D , Hamilton TA , Lane TE.The T cell chemoattractant IFN-inducible protein 10 is essential in host defense against viral-induced neurologic disease . J Immunol2000; 165: 2327-2330 .
33.
Liu MT , Keirstead HS , Lane TE.Neutralization of the chemokine CXCL10 reduces inflammatory cell invasion and demyelination and improves neurological function in a viral model of multiple sclerosis . J Immunol2001; 167: 4091-4097 .
34.
Dal Canto MC , Kim BS , Miller SD , Melvold RW.Theiler’s murine encephalomyelitis virus (TMEV)-induced demyelination: a model for human multiple sclerosis . Methods1996; 10: 453-461 .
35.
Paya CV , Patick AK , Leibson PJ , Rodriguez M.Role of natural killer cells as immune effectors in encephalitis and demyeli-nation induced by Theiler’s virus . J Immunol1989; 143: 95-102 .
36.
Mahalingam S , Farber JM , Karupiah G.The interferon-inducible chemokines MuMig and Crg-2 exhibit antiviral activity in vivo . J Virol1999; 73: 1479-1491 .
37.
Fife BT , Kennedy KJ , Paniagua MC , Lukacs NW , Kunkel SL , Luster AD , Karpus WJ.CXCL10 (IFN-g-inducible protein-10) control of encephalitogenic CD4+ T cell accumulation in the central nervous system during experimental autoimmune encephalomyelitis . J Immunol2001; 166: 7617-7624 .
38.
Tannenbaum CS , Tubbs R , Armstrong D , Finke JH , Bukowski RM , Hamilton TA.The CXC chemokines IP-10 and Mig are necessary for IL-12-mediated regression of the mouse RENCA tumor . J Immunol1998; 161: 927-932 .
39.
Tsunoda I , Wada Y , Libbey JE , Cannon TS , Whitby FG , Fujinami RS.Prolonged gray matter disease without demyelination caused by Theiler’s murine encephalomyelitis virus with a mutation in VP2 puff B . J Virol2001; 75: 7494-7505 .
40.
Tolley ND , Tsunoda I , Fujinami RS.DNA vaccination against Theiler’s murine encephalomyelitis virus leads to alterations in demyelinating disease . J Virol1999; 73: 993-1000 .
41.
Rodriguez M , Quddus J.Effect of cyclosporin A, silica quartz dust, and protease inhibitors on virus-induced demyelination . J Neuroimmunol1986; 13: 159-174 .
42.
Tsunoda I , Tolley ND , Theil DJ , Whitton JL , Kobayashi H , Fujinami RS.Exacerbation of viral and autoimmune animal models for multiple sclerosis by bacterial DNA . Brain Pathol1999; 9: 481-493 .
43.
Tsunoda I , Kuang L-Q , Fujinami RS.Induction of autoreactive CD8+ cytotoxic T cells during Theiler’s murine encephalomyelitis virus infection: Implications for autoimmunity . J Virol2002; 76: 12834-12844 .
44.
Tsunoda I , Kuang L-Q , Tolley ND , Whitton JL , Fujinami RS.Enhancement of experimental allergic encephalomyelitis (EAE) by DNA immunization with myelin proteolipid protein (PLP) plasmid DNA . J Neuropathol Exp Neurol1998; 57: 758-767 .
45.
Liu MT , Chen BP , Oertel P , Buchmeier MJ , Hamilton TA , Armstrong DA , Lane TE.The CXC chemokines IP-10 and Mig are essential in host defense following infection with a neurotropic coronavirus . Adv Exp Med Biol2001; 494: 323-327 .
46.
Dufour JH , Dziejman M , Liu MT , Leung JH , Lane TE , Luster AD.IFN-g-inducible protein 10 (IP-10; CXCL10)-deficient mice reveal a role for IP-10 in effector T cell generation and trafficking . J Immunol2002; 168: 3195-3204 .
47.
Ransohoff RM , Hamilton TA , Tani M , Stoler MH , Shick HE , Major JA , Estes ML , Thomas DM , Tuohy VK.Astrocyte expression of mRNA encoding cytokines IP-10 and JE/MCP-1 in experimental autoimmune encephalomyelitis . FASEB J1993; 7: 592-600 .
48.
Godiska R , Chantry D , Dietsch GN , Gray PW.Chemokine expression in murine experimental allergic encephalomyelitis . J Neuroimmunol1995; 58: 167-176 .
49.
Juedes AE , Hjelmström P , Bergman CM , Neild AL , Ruddle NH.Kinetics and cellular origin of cytokines in the central nervous system: Insight into mechanisms of myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis . J Immunol2000; 164: 419-426 .
50.
Izikson L , Klein RS , Charo IF , Weiner HL , Luster AD.Resistance to experimental autoimmune encephalomyelitis in mice lacking the CC chemokine receptor (CCR)2 . J Exp Med2000; 192: 1075-1080 .
51.
Wojcik WJ , Swoveland P , Zhang X , Vanguri P.Chronic intrathecal infusion of phosphorothioate or phosphodiester antisense oligonucleotides against cytokine responsive gene- 2/IP-10 in experimental allergic encephalomyelitis of Lewis rat . J Pharmacol Exp Ther1996; 278: 404-410 .
52.
Sasseville VG , Smith MM , Mackay CR , Pauley DR , Mansfield KG , Ringler DJ , Lackner AA.Chemokine expression in simian immunodeficiency virus-induced AIDS encephalitis . Am J Pathol1996; 149: 1459-1467 .
53.
Wildbaum G , Netzer N , Karin N.Plasmid DNA encoding IFN-g-inducible protein 10 redirects antigen-specific T cell polarization and suppresses experimental autoimmune encephalomyelitis . J Immunol2002; 168: 5885-5892 .
54.
Kaminsky SG , Nakamura I , Cudkowicz G.Selective defect of natural killer and killer cell activity against lymphomas in SJL mice: low responsiveness to interferon inducers . J Immunol1983; 130: 1980-1984 .
55.
Luster AD , Greenberg SM , Leder P.The IP-10 chemokine binds to a specific cell surface heparan sulfate site shared with platelet factor 4 and inhibits endothelial cell proliferation . J Exp Med1995; 182: 219-231 .
56.
Bandtlow CE , Zimmermann DR.Proteoglycans in the developing brain: new conceptual insights for old proteins . Physiol Rev2000; 80: 1267-1290 .
57.
Hamilton NHR , Banyer JL , Hapel AJ , Mahalingam S , Ramsay AJ , Ramshaw IA , Thomson SA.IFN-g regulates murine interferon-inducible T cell alpha chemokine (I-TAC) expression in dendritic cell lines and during experimental auto-immune encephalomyelitis (EAE) . Scand J Immunol2002; 55: 171-177 .
58.
Alt C , Laschinger M , Engelhardt B.Functional expression of the lymphoid chemokines CCL19 (ELC) and CCL21 (SLC) at the blood-brain barrier suggests their involvement in G-protein-dependent lymphocyte recruitment into the central nervous system during experimental autoimmune encephalomyelitis . Eur J Immunol2002; 32: 2133-2144 .
59.
Jenh C-H , Cox MA , Kaminski H , Zhang M , Byrnes H , Fine J , Lundell D , Chou C-C , Narula SK , Zavodny PJ.Species specificity of the CC chemokine 6Ckine signaling through the CXC chemokine receptor CXCR3: human 6Ckine is not a ligand for the human or mouse CXCR3 receptors . J Immunol1999; 162: 3765-3769 .
60.
Charles PC , Weber KS , Cipriani B , Brosnan CF.Cytokine, chemokine and chemokine receptor mRNA expression in different strains of normal mice: implications for establishment of a Th1/Th2 bias . J Neuroimmunol1999; 100: 64-73 .
61.
Glabinski AR , Krakowski M , Han Y , Owens T , Ransohoff RM.Chemokine expression in GKO mice (lacking interferon-gamma) with experimental autoimmune encephalomyelitis . J NeuroVirol1999; 5: 95-101 .
62.
Lublin FD , Reingold SC.Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on clinical trials of new agents in multiple sclerosis . Neurology1996; 46: 907-911 .
63.
Tsunoda I , Kuang L-Q , Theil DJ , Fujinami RS.Antibody association with a novel model for primary progressive multiple sclerosis: Induction of relapsing-remitting and progressive forms of EAE in H2S mouse strains . Brain Pathol2000; 10: 402-418 .
64.
Scarpini E , Galimberti D , Baron P , Clerici R , Ronzoni M , Conti G , Scarlato G.IP-10 and MCP-1 levels in CSF and serum from multiple sclerosis patients with different clinical subtypes of the disease . J Neurol Sci2002; 195: 41-46 .
65.
Jalonen TO , Pulkkinen K , Ukkonen M , Saarela M , Elovaara I.Differential intracellular expression of CCR5 and chemokines in multiple sclerosis subtypes . J Neurol2002; 249: 576-583 .
66.
Martínez-Cáceres EM , Espejo C , Brieva L , Pericot I , Tintoré M , Sáez-Torres I , Montalban X.Expression of chemokine receptors in the different clinical forms of multiple sclerosis . Mult Scler2002; 8: 390-395 .
67.
Sørensen TL , Sellebjerg F.Distinct chemokine receptor and cytokine expression profile in secondary progressive MS . Neurology2001; 57: 1371-1376 .
68.
Sørensen TL , Sellebjerg F.Selective suppression of chemokine receptor CXCR3 expression by interferon-b1a in multiple sclerosis . Mult Scler2002; 8: 104-107 .
